The first in vitro diagnostic test to detect brain plaques tied to Alzheimer’s disease can now be marketed to clinicians, the Food and Drug Administration announced this week. The Lumipulse G ...
CITCCA data demonstrate more than 40% of high-risk stage I–III colorectal patients harbor molecular residual disease at clinical landmark, detectable only with ultrasensitive ctDNA testingMORRISVILLE, ...
An Aston University researcher has developed a new technique using light which could revolutionize non-invasive medical diagnostics and optical communication. The research showcases how a type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback